Editorial
Time for a reassessment of the use of Kava in anxiety?

https://doi.org/10.1016/j.ctim.2009.01.003Get rights and content

Section snippets

Conflict of interest

None.

References (9)

  • D. Coulter

    Assessment of the risk of hepatotoxicity with Kava products

    WHO appointed committee

    (2007)
  • R. Kava

    The adverse effects of kava

    Pacific Health Dialog

    (2001)
  • R. Moulds et al.

    Kava: herbal panacea or liver poison?

    Medical Journal of Australia

    (2003)
  • A. Jowitt et al.

    The commercialisation of Kava in Vanuatu

    Pacific Health Dialog

    (2001)
There are more references available in the full text version of this article.

Cited by (0)

View full text